Biosurgical Agents – Market Insights – Europe (Supplemental)

The biosurgical agent market in Europe will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides high-level market metrics for biosurgical agents in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2032.